OSU-A9

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOSU-A9
Drug Alias Nameindole-3-carbinol-derived antitumor agent (China Medical University)OSU-A9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 modulatorsP38 α mitogen-activated protein kinase stimulants
TargetsSignal transducer and activator of transcription 3P38 α mitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChina Medical University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChina Medical University Hospital
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A